NCT02231359View on ClinicalTrials.gov

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

CompletedOBSERVATIONAL
Enrollment

2,006

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual® Respimat® solution for inhalation

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY